Impaired resistance artery function in patients with end-stage renal disease

Clinical Science

Volumn 120, Issue 12, 2011, Pages 525-536

  Luksha, Natallia ^a   Luksha, Leanid ^a   Carrero, Juan Jesús ^a   Hammarqvist, Folke ^a   Stenvinkel, Peter ^a   Kublickiene, Karolina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular disease; Diabetes; End stage renal disease; Endothelium; Flow mediated dilatation; Nitric oxide; Resistance artery

Indexed keywords

3 NITROTYROSINE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR;

ADULT; AGED; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; UREMIA;

ADULT; AGED; ARTERIES; ENDOTHELINS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NITRIC OXIDE; VASCULAR RESISTANCE; VASODILATION;

EID: 79952578294     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100277     Document Type: Article

References (53)

1. Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. and Hsu, C. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296-1305
2. Stenvinkel, P., Carrero, J. J., Axelsson, J., Lindholm, B., Heimburger, O. and Massy, Z. (2008) Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin. J. Am. Soc. Nephrol. 3, 505-521
3. Endemann, D. H. and Schiffrin, E. L. (2004) Endothelial dysfunction. J. Am. Soc. Nephrol. 15, 1983-1992
4. Stam, F., van Guldener, C., Becker, A., Dekker, J. M., Heine, R. J., Bouter, L. M. and Stehouwer, C. D. (2006) Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J. Am. Soc. Nephrol. 17, 537-545
5. Sahin, G., Yalcin, A. and Akcar, N. (2007) Effect of n-acetylcysteine on endothelial dysfunction in dialysis patients. Blood Purif. 25, 309-315
6. Verbeke, F. H., Agharazii, M., Boutouyrie, P., Pannier, B., Guerin, A. P. and London, G. M. (2007) Local shear stress and brachial artery functions in end-stage renal disease. J. Am. Soc. Nephrol. 18, 621-628
7. Safar, M. E., London, G. M. and Plante, G. E. (2004) Arterial stiffness and kidney function. Hypertension 43, 163-168
8. Guérin, A. P., Pannier, B., Marchais, S. J. and London, G. M. (2008) Arterial structure and function in end-stage renal disease. Curr. Hypertens Rep. 10, 107-111
9. Savage, T., Tribe, R. M. and Yaqoob, M. M. (2001) Flow induces dilatation in the femoral artery of uraemic rats but constriction in control rats. Nephrol Dial. Transplant. 16, 1156-1162
10. Bagi, Z., Hamar, P., Antus, B., Rosivall, L. and Koller, A. (2003) Chronic renal failure leads to reduced flow-dependent dilation in isolated rat skeletal muscle arterioles due to lack of NO mediation. Kidney Blood Press. Res. 26, 19-26
11. Morris, S. T., McMurray, J. J., Spiers, A. and Jardine, A. G. (2001) Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int. 60, 1077-1082
12. Passauer, J., Büssemaker, E., Range, U., Plug, M. and Gross, P. (2000) Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilation in normotensive patients on chronic hemodialysis. J. Am. Soc. Nephrol. 11, 1726-1734
13. Passauer, J., Pistrosch, F., Lassig, G., Herbrig, K., Bussemaker, E., Gross, P. and Fleming, I. (2005) Nitric oxide- and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9. Kidney Int. 67, 1907-1912 (Pubitemid 40577726)
14. Passauer, J., Pistrosch, F., Bussemaker, E., Lassig, G., Herbrig, K. and Gross, P. (2005) Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. J. Am. Soc. Nephrol. 16, 959-965
15. Chin-Dusting, J. P., Cameron, J. D., Dart, A. M. and Jennings, G. L. (1999) Human forearm venous occlusion plethysmography: methodology, presentation and analysis. Clin. Sci. 96, 439-440
16. Ferns, G., Shams, S. and Shafi, S. (2006) Heat shock protein 27: its potential role in vascular disease. Int. J. Exp. Pathol. 87, 253-274
17. Bielecka-Dabrowa, A., Barylski, M., Mikhailidis, D. P., Rysz, J. and Banach, M. (2009) Hsp 70 and atherosclerosis - protector or activator? Expert Opin. Ther. Targets 13, 307-317
18. Pritchard, K. A., Ackerman, A., Gross, E. R., Stepp, D. W., Shi, Y., Fontana, J. T., Baker, J. E. and Sessa, W. C. (2001) Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J. Biol. Chem. 276, 17621-17624
19. Ischiropoulos, H. (1998) Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356, 1-11
20. Leone, A., Moncada, S., Vallance, P., Calver, A. and Collier, J. (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339, 572-575
21. Luksha, L., Nisell, H. and Kublickiene, K. (2004) The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R1102-R1109
22. Takacs, P., Gualtieri, M., Nassiri, M., Candiotti, K. and Medina, C. (2008) Vaginal smooth muscle cell apoptosis is increased in women with pelvic organ prolapse. Int. Urogynecol. J. 19, 1559-1564
23. Rangan, G. and Tesch, G. (2007) Quantification of renal pathology by image analysis (methods in renal research). Nephrology 12, 553-558 (Pubitemid 350059130)
24. Annuk, M, Soveri, I., Zilmer, M., Lind, L., Hulthe, J. and Fellström, B. (2005) Endothelial function, CRP and oxidative stress in chronic kidney disease. J. Nephrol. 18, 721-726
25. Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J., Safar, M. E. and London, G. M. (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99, 2434-2439
26. Peralta, C. A., Katz, R., Madero, M., Sarnak, M., Kramer, H., Criqui, M. H. and Shlipak, M. G. (2009) The differential association of kidney dysfunction with small and large arterial elasticity: the multiethnic study of atherosclerosis. Am. J. Epidemiol. 169, 740-748
27. Davies, P. F. (2009) Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat. Clin. Pract. Cardiovasc. Med. 6, 16-26
28. Cockell, A. P. and Poston, L. (1997) Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 30, 247-251 (Pubitemid 27329005)
29. Paniagua, O. A., Bryant, M. B. and Panza, J. A. (2001) Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation 103, 1752-1758
30. Yilmaz, M. I., Saglam, M., Caglar, K., Cakir, E., Ozgurtas, T., Sonmez, A., Eyileten, T., Yenicesu, M., Acikel, C., Oguz, Y., Ozcan, O., Bozlar, U., Erbil, K., Aslan, I. and Vural, A. (2005) Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation 80, 1660-1666 (Pubitemid 43053988)
31. Baylis, C. (2008) Nitric oxide deficiency in chronic kidney disease. Am. J. Physiol. Renal Physiol. 294, F1-F9
32. Himmelfarb, J., Stenvinkel, P., Ikizler, T. A. and Hakim, R. M. (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 62, 1524-1538
33. Yilmaz, M. I., Sonmez, A., Saglam, M., Qureshi, A. R., Carrero, J. J., Caglar, K., Eyileten, T., Cakir, E., Oguz, Y., Vural, A., Yenicesu, M., Lindholm, B., Stenvinkel, P. and Axelsson, J. (2008) ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction. J. Am. Soc. Nephrol. 19, 388-395
34. Förstermann, U. (2006) Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol. Chem. 387, 1521-1533
35. Ibrahim, J., McGee, A., Graham, D., McGrath, J. C. and Dominiczak, A. F. (2006) Sex-specific differences in cerebral arterial myogenic tone in hypertensive and normotensive rats. Am. J. Physiol. Heart Circ. Physiol. 290, H1081-H1089
36. Izzard, A., Bund, S. J. and Heagerty, A. M. (1996) Myogenic tone in mesenteric arteries from spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 270, H1-H6
37. New, D. I., Chesser, A. M., Raftery, M. J. and Yaqoob, M. M. (2003) The myogenic response in uremic hypertension. Kidney Int. 63, 642-646
38. Osol, G. and Halpern, W. (1986) Effect of antihypertensive treatment on myogenic properties of brain arteries from the stroke-prone rat. J. Hypertens 4, S517-S518 (Pubitemid 17209557)
39. Vettoretti, S., Ochodnicky, P., Buikema, H., Henning, R., Kluppel, C., de Zeeuw, D. and van Dokkum, R. (2006) Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats. J. Hypertens. 24, 2215-2223 (Pubitemid 44611031)
40. Koyama, H., Nishzawa, Y., Morii, H., Tabata, T., Inoue, T. and Yamaji, T. (1989) Plasma endothelin levels in patients with uraemia. Lancet 333, 991-992 (Pubitemid 19123577)
41. Ruiz-Ortega, M., Ruperez, M., Esteban, V., Rodriguez-Vita, J., Sanchez-Lopez, E., Carvajal, G. and Egido, J. (2006) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol. Dial. Transplant. 21, 16-20
42. Rump, L. C., Amann, K., Orth, S. and Ritz, E. (2000) Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol. Dial. Transplant. 15, 1735-1738
43. Aalkjaer, C., Pedersen, E., Danielsen, H., Fjeldborg, O., Jespersen, B., Kjaer, T., Sørensen, S. S. and Mulvany, M. J. (1986) Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin. Sci. (Lond). 71, 657-663
44. Amann, K. and Ritz, E. (2000) Microvascular disease - the Cinderella of uraemic heart disease. Nephrol. Dial. Transplant. 15, 1493-1503
45. Agabiti-Rosei, E., Heagerty, A. and Rizzoni, D. (2009) Effects of antihypertensive treatment on small artery remodelling. J. Hypertens. 27, 1107-1114
46. Rigsby, C. S., Pollock, D. M. and Dorrance, A. M. (2007) Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats. Microvasc. Res. 73, 198-205
47. Briones, A. M., Gonzalez, J. M., Somoza, B., Giraldo, J., Daly, C. J., Vila, E., Gonzalez, M. C., McGrath, J. C. and Arribas, S. M. (2003) Role of elastin in spontaneously hypertensive rat small mesenteric artery remodelling. J. Physiol. 552, 185-195
48. Yamamoto, Y., Sakata, N., Meng, J., Sakamoto, M., Noma, A., Maeda, I., Okamoto, K. and Takebayashi, S. (2002) Possible involvement of increased glycoxidation and lipid peroxidation of elastin in atherogenesis in haemodialysis patients. Nephrol. Dial. Transplant. 17, 630-636
49. Meng, J., Sakata, N. and Takebayashi, S. (2000) Increased glycoxidation and lipoperoxidation in the collagen of the myocardium in hemodialysis patients. Cardiovasc. Res. 47, 306-313
50. Vlassara, H. (1994) Recent progress on the biologic and clinical significance of advanced glycosylation end products. J. Lab. Clin. Med. 124, 19-30
51. Feihl, F., Liaudet, L., Levy, B. I. and Waeber, B. (2008) Hypertension and microvascular remodelling. Cardiovasc Res. 78, 274-285 (Pubitemid 351556101)
52. Christensen, K. and Mulvany, M. (2001) Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J. Hypertens. 19, 1001-1006 (Pubitemid 32493631)
53. Schiffrin, E. L. (2004) Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatments. Am. J. Hypertens. 17, 1192-1200